Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN-003 Rollover Trial in Genital HSV-2
NCT02300142Phase 2Completed
- Sponsor
- Genocea Biosciences
- Start
- Jan 2015
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GEN-003 in Genital Herpes Type 2 (HSV-2), sponsored by Genocea Biosciences. Started Jan 2015; status: completed.
02
Drugs
GEN-003
03
Conditions
Genital Herpes Type 2 (HSV-2)
Beyond the preview
Go deeper on NCT02300142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300142.